← Insider buys
TCON

Tracon Pharmaceuticals, Inc.

Opaleye Management Inc. bought $30K of Tracon Pharmaceuticals, Inc.

10% owner

Bought$29,943
$1.73Price
17,311Shares

What TCON did for a copier

Prices for TCON after this filing aren't in yet.

Opaleye Management Inc.'s record

63 other buys with 3 months of prices since 2016: on average +20.3% against the S&P 500, and 33 of 63 beat it.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Thu, Sep 22. Filed Thu, Sep 22, 6:09 PM ET, after the close. Not investment advice.